
Next-gen clinical data management system
Leverage advanced clinical data management systems (CDMS) to provide high-quality data to streamline and accelerate faster drug discovery and time-to-market.
Stay ahead of the curve with next-gen CDMS

The evolution of the clinical research industry, over the last decade, has led to the development of advanced clinical data management systems. These systems enable real-time data integration, data standardization at different layers, risk-based monitoring, real-time data reviews, and advanced analytics for life sciences companies. Future-forward companies are adopting next-gen CDMS to:
- solve the clinical data aggregation and visibility constraints for better outcomes.
- provide robust controls to implement data quality and governance.
- enable data validations across clinical data sets as per business rules.
Leverage next-gen non-transactional, self-serve, and customizable CDMS for real-time data collection and aggregation. Extract data’s greatest value to streamline and fast-track drug discovery and time-to-market!

Read Article / 5 reasons for the switch from clinical data management to clinical data science
Next-gen clinical data management system
Robust data aggregation
Tailored semantic for complex business rules
Clinical decision support
Built to scale
Service offering
Key results
Business outcomes
- Agile clinical development
- Clinical development optimization
- Left shift of data services
- Meeting your needs with the next-gen CDMS

Customized and assembled platform with accelerators

Greater visibility and control over the data

Manage trials with agility and speed

Replace legacy systems and remove vendor lock-in
Digital trials
- Continuous and confidential collection of data and eSource information.
- Securely manage data sources and harmonize with performance analytics and remote monitoring.
- Reimagine the process to drive automation for clinical data, from protocol to submission.
Analyzing R&D strategy
- Global regulatory and compliance insight for fast regulatory approval.
Axtria clinical research hub

Blog